Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.52 |
| ▸ | RAB9A | P51151 | 4/20 | 0.52 |
| ▸ | NPC1 | O15118 | 3/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetophenone SCHEMBL28104067 | 0.89 | PKM (0.55) | MAPTSMN1; SMN2RAB9ANPC1TAAR1 | |
| SCHEMBL5692310 | 0.85 | ALDH1A1 (0.44) | MAPTSMN1; SMN2RAB9ANPC1CA12 | |
| SCHEMBL400499 | 0.83 | TP53 (0.52) | MAPTSMN1; SMN2RAB9ANPC1CA12 | |
| SCHEMBL29051542 | 0.83 | ALDH1A1 (0.46) | MAPTSMN1; SMN2RAB9ANPC1CA12 | |
| SCHEMBL31722027 | 0.82 | SMN1; SMN2 (0.71) | MAPTSMN1; SMN2RAB9ANPC1TAAR1 | |
| Methane SCHEMBL364406 | 0.82 | TP53 (0.50) | MAPTSMN1; SMN2RAB9ANPC1CA12 | |
| SCHEMBL11718244 | 0.81 | RAB9A (0.71) | MAPTSMN1; SMN2RAB9ANPC1CA12 | |
| SCHEMBL6644241 | 0.81 | HDAC2 (0.52) | MAPTSMN1; SMN2RAB9ANPC1CA2 | |
| SCHEMBL11760216 | 0.80 | SMN1; SMN2 (0.57) | MAPTSMN1; SMN2RAB9ANPC1TAAR1 | |
| SCHEMBL8639589 | 0.80 | L3MBTL1 (0.46) | MAPTSMN1; SMN2RAB9ANPC1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4946761-A | POLYMER CONTAINING CARBOXYL END GROUPS | FUJI PHOTO FILM CO., LTD. (JP) | 1990-08-07 | — | — | US | claimed |
| EP-4397677-A1 | HUMAN INTERLEUKIN 2-POLYETHYLENE GLYCOL CONJUGATE AND USE THEREOF | Novocodex Biopharmaceuticals Co., Ltd. (CN) | 2024-07-10 | — | — | EP | disclosed |
| WO-2023004686-A1 | UNNATURAL AMINO ACID, AND USE THEREOF, RECOMBINANT PROTEIN CONTAINING SAME, AND RECOMBINANT PROTEIN CONJUGATE | 浙江新码生物医药有限公司 | 2023-02-02 | — | — | WO | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-9428478-B2 | Piperazine derivatives, compositions, and uses related thereto | EMORY UNIVERSITY (US) | 2016-08-30 | — | — | US | disclosed |
| US-9428478-B2 | Piperazine derivatives, compositions, and uses related thereto | EMORY UNIVERSITY (US) | 2016-08-30 | — | — | US | disclosed |
| US-20140194422-A1 | PIPERAZINE DERIVATIVES, COMPOSITIONS, AND USES RELATED THERETO | EMORY UNIVERSITY (US) | 2014-07-10 | — | — | US | disclosed |
| US-20140194422-A1 | PIPERAZINE DERIVATIVES, COMPOSITIONS, AND USES RELATED THERETO | EMORY UNIVERSITY (US) | 2014-07-10 | — | — | US | disclosed |
| WO-2012173952-A1 | PIPERAZINE DERIVATIVES, COMPOSITIONS, AND USES RELATED THERETO | EMORY UNIVERSITY (US) | 2012-12-20 | — | — | WO | disclosed |
| WO-2012173952-A1 | PIPERAZINE DERIVATIVES, COMPOSITIONS, AND USES RELATED THERETO | EMORY UNIVERSITY (US) | 2012-12-20 | — | — | WO | disclosed |
| EP-0458485-B1 | Image forming layer | FUJI PHOTO FILM CO LTD (JP) | 1998-07-29 | — | — | EP | disclosed |
| US-5395733-A | Unsaturated polymer layer that can be decarboxylated on exposure to light and sensitizers | FUJI PHOTO FILM CO., LTD. (JP) | 1995-03-07 | — | — | US | disclosed |
| EP-0458485-A2 | Image forming layer | Fuji Photo Film Co., Ltd. (JP) | 1991-11-27 | — | — | EP | disclosed |
| US-4946761-A | POLYMER CONTAINING CARBOXYL END GROUPS | FUJI PHOTO FILM CO., LTD. (JP) | 1990-08-07 | — | — | US | disclosed |
| US-4405705-A | HYDROPHILIC | TOYO BOSEKI KABUSHIKI KAISHA T/A TOYOBA CO., LTD. (JP) | 1983-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140194422-A1 | PIPERAZINE DERIVATIVES, COMPOSITIONS, AND USES RELATED THERETO | NOX4, NOX5, NOXO1 | MAPT 2289/4885SMN1; SMN2 3107/4885RAB9A 3090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.